Resurrect Bio

About Resurrect Bio

Resurrect Bio is a company focused on helping crops defeat diseases by resurrecting R-genes, enabling crops to defend themselves. Their mission is to revolutionize agricultural technology through proprietary AI and rapid plant platforms.

Products & Services

FloraFold(r) AI Technology:An in-house AI technology that guides a rapid trait discovery platform, revolutionizing time to field for crop traits.

Rapid Trait Discovery Platform:A high-throughput, proprietary in-silico and in-planta workflow that discovers traits up to 5x faster than traditional methods, applicable to any crop, most pathogens, and many pests, with GE regulatory compliance.

Specialties

AI in Agriculture Trait Discovery Crop Immunity Regulatory Compliance in Genetic Engineering

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 2012500 MR: - FA: £1.61M FAN: 2012500	D: 2023-05-16 FD: 2023-05-16	4 investors

Seed Latest

2023-05-16

$2.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Cian Duggan

CEO & Co-Founder

T

Tolga Bozkurt

Co-Founder

S

Sophien Kamoun

Co-Founder

P

Pankhuri Srivastava

Research Technician

I

Imogen Binnian

Lead Biologist

D

Doko-Miles Thorburn

Lead Computational Biologist

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Resurrect Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised